🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareSemaglutide and addictive behavior reduction — need advice Page 3

Semaglutide and addictive behavior reduction — need advice

Dr.RenalNash Fri, Sep 19, 2025 at 1:34 AM 30 replies 1,683 viewsPage 3 of 6
HPLC_Greg
Senior Member
1,890
8,901
Feb 2024
Research Triangle, NC
Sep 20, 2025 at 10:28 AM#11
PedsEndoPhilly said:
The useful move here is to separate what is established from what is widely repeated.

That holds for the injectable. The oral formulation has different absorption behaviour and the dose numbers are not interchangeable, which is worth saying out loud because people quote them as if they were.

Last edited: Sep 20, 2025 at 4:28 PM
10 10SallyK_inj, CryptoCarl, MariaRD and 7 others
Reply Quote Save Share Report
RunnerRach
Member
467
2,123
Aug 2024
Boston, MA
Sep 20, 2025 at 1:35 PM#12
Dr.MetabolicMD said:
The mechanism that matters here is not stomach emptying, it is central.

Saving this. It is the first explanation that did not require me to already understand it. Taking it to my next appointment.

9 9MikeKY_noInsulin, Dr.RaviCardio, jennifer_SEA and 6 others
Reply Quote Save Share Report
kate.chem
VIP Member
3,890
17,654
Dec 2023
California
Sep 20, 2025 at 4:42 PM#13
PedsEndoPhilly said:
The useful move here is to separate what is established from what is widely repeated.

I read this differently from PedsEndoPhilly, on substance rather than tone. The trial means are being read too generously in this thread. STEP populations were selected, supported, and titrated by protocol, and the real-world curves are consistently a few points worse. That difference is not noise, it is what happens when you remove the study infrastructure.

8 8tyler_CSCS, VanRx_Mike, steve_okc and 5 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Sep 20, 2025 at 7:49 PM#14

The figures, for anyone assembling their own picture. One practical note: write down what you did and when, before you need it. Reconstructing a timeline from memory three months later is how people end up unable to answer the one question that would have resolved it.

7 7Dr.PulmRoch, maya_sedona, stefan_berlin and 4 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Sep 20, 2025 at 10:56 PM#15

Moderator note: a post naming a supplier has been edited. Discuss suppliers in the review sections, not here.

6 6PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 3 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register